International Journal of Peptide Research and Therapeutics
Scope & Guideline
Elevating Knowledge in Peptide Research and Therapeutics.
Introduction
Aims and Scopes
- Therapeutic Applications of Peptides:
The journal investigates the use of peptides in various therapeutic contexts, including antimicrobial, anticancer, anti-inflammatory, and immunomodulatory applications. This includes the study of naturally occurring peptides, synthetic analogs, and engineered peptide constructs. - Peptide Design and Engineering:
Research published in this journal often focuses on the design, synthesis, and characterization of novel peptides. This includes the use of computational approaches, molecular docking, and structure-activity relationship studies to optimize peptide efficacy and specificity. - Mechanisms of Action:
The journal emphasizes understanding the biochemical and molecular mechanisms through which peptides exert their effects, including studies on signal transduction pathways, receptor interactions, and cellular responses. - Bioinformatics and Computational Modeling:
A significant portion of the research involves computational methods for predicting peptide interactions, designing peptide-based vaccines, and simulating the behavior of peptides in biological systems. - Natural Product Research:
The journal highlights the exploration of peptides derived from natural sources, including plants, animals, and microorganisms, and their potential therapeutic benefits. - Multidisciplinary Approaches to Peptide Research:
Research often integrates various scientific disciplines such as biochemistry, molecular biology, pharmacology, and materials science to advance the field of peptide therapeutics.
Trending and Emerging
- Antimicrobial Peptides (AMPs):
There is a growing body of research focused on the discovery, characterization, and application of antimicrobial peptides as alternatives to conventional antibiotics, particularly in addressing multidrug-resistant pathogens. - Peptide Vaccines:
The development of peptide-based vaccines, particularly in response to emerging infectious diseases such as COVID-19, has gained significant attention, with many studies exploring immunogenicity and efficacy. - Peptides in Cancer Therapy:
Research on peptides that target cancer cells, including their mechanisms of action and potential as therapeutic agents, is rapidly expanding, with a focus on novel delivery systems and combination therapies. - AI and Machine Learning in Peptide Design:
The integration of artificial intelligence and machine learning techniques in peptide design and optimization is emerging as a powerful tool, enhancing the ability to predict peptide interactions and therapeutic potential. - Natural and Synthetic Hybrid Peptides:
There is an increasing interest in hybrid peptides that combine properties of natural and synthetic peptides, aiming to enhance stability and efficacy for therapeutic applications. - Peptides for Neurological Disorders:
Research on the role of peptides in the treatment of neurological conditions, including neurodegenerative diseases and neuroinflammation, is on the rise, highlighting their therapeutic potential in the central nervous system.
Declining or Waning
- Traditional Antibiotics:
There appears to be a waning interest in the development of traditional peptide antibiotics as researchers increasingly focus on innovative approaches, such as multifunctional peptides or peptide-drug conjugates, to combat antibiotic resistance. - Peptides for General Health Supplements:
Research focused on the use of peptides exclusively for general health benefits or as dietary supplements is becoming less prominent, indicating a shift toward more targeted therapeutic applications. - Peptide-Based Diagnostics:
The exploration of peptides specifically for diagnostic applications has decreased, possibly as the field shifts towards integrated approaches that combine diagnostics with therapeutic interventions. - Basic Research in Peptide Chemistry:
While fundamental studies are essential, there is a noticeable decline in publications that focus solely on the basic chemistry of peptides without direct therapeutic implications, reflecting a trend toward more applied research.
Similar Journals
LETTERS IN ORGANIC CHEMISTRY
Shaping the Future of Organic Chemistry ResearchLETTERS IN ORGANIC CHEMISTRY is a distinguished journal published by Bentham Science Publishers Ltd, focusing on the rapidly evolving field of organic chemistry. Established in 2005, the journal commits itself to disseminating vital research findings, reviews, and innovative methodologies that contribute to the understanding and advancement of organic chemistry and biochemistry. With an ISSN of 1570-1786 and an E-ISSN of 1875-6255, this journal enhances accessibility and visibility for authors and readers alike, albeit not adopting an open-access model. Positioned within Q4 quartile rankings for both Biochemistry and Organic Chemistry, it serves a niche audience keen on exploring emerging trends and breakthroughs in these disciplines. Its Scopus rankings further reflect its role in the global academic landscape, albeit at the beginning stages of its impact journey. Based in the United Arab Emirates, LETTERS IN ORGANIC CHEMISTRY is dedicated to fostering dialogue among researchers and practitioners, paving the way for future innovations in organic and biochemical sciences.
MOLECULAR DIVERSITY
Unveiling Innovations in Molecular DiversityMOLECULAR DIVERSITY, published by Springer, stands as a pivotal platform within the fields of chemistry, biology, and pharmacology since its inception in 1995. This esteemed journal aims to foster interdisciplinary research and innovation, particularly in areas such as catalysis, drug discovery, inorganic and organic chemistry, and molecular biology. With a diverse scope that reflects contemporary scientific challenges, it has been recognized for its significant contributions, boasting commendable Scopus rankings and an impact factor that underscores its relevance in critical fields. Although not an open access journal, MOLECULAR DIVERSITY continues to influence and engage researchers, professionals, and students alike by providing a forum for high-quality peer-reviewed articles and cutting-edge research findings. As it converges years of scientific dynamism from 1995 to 2024, this journal remains vital for those advancing the frontiers of molecular science and engineering.
JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION
Driving Innovation in Biochemical ResearchJOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION, published by TAYLOR & FRANCIS LTD, is a premier academic journal dedicated to advancing our understanding of receptor biology and signal transduction mechanisms. With an ISSN of 1079-9893 and an E-ISSN of 1532-4281, this journal has maintained a reputable standing since its inception in 1980, continually addressing pivotal topics in biochemistry, cell biology, and molecular biology. As evidenced by its 2023 Scopus rankings, which place it in the 64th percentile for Biochemistry and Genetics and Molecular Biology, JOURNAL OF RECEPTORS AND SIGNAL TRANSDUCTION remains a vital source for cutting-edge research, providing insights that are essential for both academic and practical applications. Although the journal currently offers limited open access options, it stands out in the Q2 and Q3 quartiles of its respective categories, making it an invaluable resource for researchers, professionals, and students aiming to stay abreast of the latest findings and methodologies in receptor and signaling research. The journal's commitment to disseminating high-quality research underscores its significance within the scientific community, fostering innovation and collaboration across disciplines.
Future Medicinal Chemistry
Unveiling cutting-edge discoveries in medicinal chemistry.Future Medicinal Chemistry is a premier journal dedicated to the rapidly evolving fields of drug discovery, pharmacology, and molecular medicine. Published by Newlands Press Ltd in the United Kingdom, this journal has garnered significant attention within the academic community, evidenced by its 2023 category rankings in Scopus, placing it in the Q2 quartile for Drug Discovery and the Q3 quartiles for both Molecular Medicine and Pharmacology. With an ISSN of 1756-8919 and an E-ISSN of 1756-8927, Future Medicinal Chemistry has been a cornerstone of scholarly discourse since its inception in 2009, continuously contributing to the advancement of knowledge and discussion in medicinal chemistry. The journal is committed to publishing high-quality, peer-reviewed research that addresses the challenges and innovations in drug development and therapeutic strategies, making it an essential resource for researchers, professionals, and students seeking to stay at the forefront of these critical fields. Engage with the latest findings and methodologies that shape the future of medicine by exploring the wealth of information offered within Future Medicinal Chemistry.
CURRENT DRUG TARGETS
Elevating Drug Discovery to New HeightsCURRENT DRUG TARGETS is a leading peer-reviewed journal dedicated to advancements in the fields of Clinical Biochemistry, Drug Discovery, Molecular Medicine, and Pharmacology. Published by Bentham Science Publishers Ltd, this esteemed journal has solidified its position in the academic community with a 2023 Q2 ranking in several categories, highlighting its influence and relevance in drug research and development. With an ISSN of 1389-4501 and E-ISSN 1873-5592, CURRENT DRUG TARGETS facilitates the dissemination of high-quality articles that explore novel therapeutic strategies and drug design principles. Catered to researchers, professionals, and students, the journal has a commitment to advancing knowledge while addressing contemporary challenges in pharmacological sciences. As it converges from 2000 to 2024, CURRENT DRUG TARGETS remains a vital resource in understanding the complexities of drug action and interaction, making it indispensable for anyone pursuing cutting-edge research in related disciplines.
BIOCHEMICAL PHARMACOLOGY
Transforming pharmaceutical applications with biochemical knowledge.BIOCHEMICAL PHARMACOLOGY, published by PERGAMON-ELSEVIER SCIENCE LTD, stands as a leading international journal devoted to the advancing field of biochemical pharmacology. Since its inception in 1958, the journal has continuously offered a platform for innovative research, delivering critical insights into the interaction between biochemical processes and pharmaceutical applications, and now converges towards its 2024 edition. With an impressive Q1 ranking in both Biochemistry and Pharmacology categories, it ranks 32nd out of 313 in Pharmacology and Toxicology, and 58th out of 438 in Biochemistry according to Scopus, showcasing its significant impact within the scientific community. Researchers and professionals rely on this journal to keep abreast of essential developments, given its robust peer-review process and a comprehensive selection of articles that span experimental studies, clinical trials, and theoretical analyses. Although not an Open Access journal, it remains pivotal for those seeking to advance their knowledge in the dynamic fields of biochemistry and pharmacology. With its high impact factor and emphasis on quality research, BIOCHEMICAL PHARMACOLOGY continues to be an invaluable resource for students, researchers, and industry professionals striving to make breakthroughs in drug development and therapeutic strategies.
ACS Bio & Med Chem Au
Advancing the frontiers of biochemistry and medicinal chemistry.ACS Bio & Med Chem Au, published by the esteemed American Chemical Society, stands at the forefront of interdisciplinary research within the realms of biochemistry, drug discovery, pharmaceutical sciences, and molecular biology. With an impressive Impact Factor indicative of its rigorous academic standards and significant contributions to the field, this open-access journal is committed to disseminating high-quality research that drives innovation and advancements in biosciences and medicinal chemistry. Since its inception in 2021, the journal has rapidly earned recognition, achieving a commendable Q1 ranking in multiple categories, including Biochemistry, Drug Discovery, and Pharmaceutical Science, while also making strides in Molecular Biology. Researchers, professionals, and students alike can explore pioneering studies that bridge gaps between laboratory research and clinical applications, fostering collaborative efforts towards novel therapeutic strategies. With a focus on enhancing accessibility and engagement within the scientific community, ACS Bio & Med Chem Au is poised to impact the future of biomedical research significantly.
JOURNAL OF PEPTIDE SCIENCE
Discovering the intricacies of peptide synthesis and function.JOURNAL OF PEPTIDE SCIENCE, published by Wiley, is a vital resource for researchers and professionals in the fields of biochemistry, drug discovery, and molecular biology. Established in 1995 and encompassing research through 2024, this journal provides a platform for disseminating cutting-edge studies related to peptide synthesis, structure, function, and applications in therapeutics. Although it currently does not offer open access, its robust content has earned it a respectable Q3 ranking in several categories, including biochemistry and pharmacology, according to the latest metrics. Researchers will find significant insights linked to peptide chemistry and its implications in medical sciences, making the JOURNAL OF PEPTIDE SCIENCE an essential addition to academic libraries and for those passionate about peptide research and its potential breakthroughs.
European Journal of Medicinal Chemistry Reports
Bridging the gap between lab research and real-world applications.European Journal of Medicinal Chemistry Reports, published by ELSEVIER, is a vital platform dedicated to advancing the field of medicinal chemistry through open access communication of high-quality research. With an impact factor reflecting its growing influence, this journal has rapidly established a reputation for scholarly excellence since its launch in 2021. It serves as a converging point for innovative studies and reviews that span the disciplines of chemistry and molecular medicine, reflected in its Q2 and Q3 quartile rankings in relevant categories for 2023. Situated in France, the journal is accessible globally, ensuring that researchers, professionals, and students can easily engage with significant findings and methodologies in medicinal chemistry. The open access model facilitates the dissemination of knowledge, bridging gaps between laboratory research and practical applications in drug development. By fostering collaboration and highlighting emerging trends, the European Journal of Medicinal Chemistry Reports plays a crucial role in shaping the future of therapeutic innovations.
Natural Product Communications
Advancing Research in Natural Remedies and BeyondNatural Product Communications is an esteemed open-access journal published by SAGE Publications Inc, dedicated to the exploration and dissemination of knowledge concerning natural products in diverse fields, including Complementary and Alternative Medicine, Drug Discovery, and Pharmacology. Since its inception in 2006 and continuing through its converged years until 2024, the journal has gained recognition with a robust focus on plant science and the medicinal properties of natural products. With a commendable impact factor reflected in its category quartiles (Q3 across key domains), Natural Product Communications serves as a vital resource for researchers and professionals who aim to further the understanding of the therapeutic potential of natural compounds. As an open-access journal since 2020, it ensures wide accessibility to its published research, thereby facilitating collaboration and innovation within the scientific community. This commitment to excellence makes Natural Product Communications a crucial platform for advancing research in the holistic and pharmacological sciences.